Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Condition(s):Iron OverloadLast Updated:February 9, 2012Approved for marketing
Hide Studies Not Open or Pending
Condition(s):Iron OverloadLast Updated:February 9, 2012Approved for marketing
Condition(s):ThalassemiaLast Updated:June 29, 2017Completed
Condition(s):Iron Overload; ThalassemiaLast Updated:January 14, 2010Completed
Condition(s):Myelodysplastic Syndrome; Iron OverloadLast Updated:August 16, 2021Completed
Condition(s):Diabetes Mellitus; Heart Disease; Hemochromatosis; ThalassemiaLast Updated:December 12, 2019Completed
Condition(s):Rheumatoid ArthritisLast Updated:December 4, 2023Suspended
Condition(s):Beta-thalassemia Major Complicated With DiabetesLast Updated:February 25, 2019Completed
Condition(s):Anemia (Iron-Loading); Beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron OverloadLast Updated:September 21, 2022Completed
Condition(s):Beta-thalassemia; Iron OverloadLast Updated:June 14, 2021Completed
Condition(s):Metastatic Malignant Solid Neoplasm; LymphomaLast Updated:October 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.